Management

CEO, CSO and Chairman: Donovan B. Yeates, PhD, founder of KAER Biotherapeutics, is an international authority in respiratory physiology and aerosol deposition and clearance. He is the inventor and developer of SUPRAER™.   He has been CEO of BioTechPlex since its inception in 1996. Three additional companies were started as a result of the IP generated in BioTechPlex   As a Senior Research Career Scientist in the Department of Veterans Affairs he directed a respiratory research program.   At the University of Illinois at Chicago , he created a Section of Environmental and Occupational Medicine in the Department of Medicine and turned around a university-wide Occupational Health and Safety Center .   Dr. Yeates is presently an emeritus professor with over 90 publications. He is a past president of the Chicago Thoracic Society and served on the Board of Directors of Illinois Biotechnology Organization (IBIO).   He has a Ph.D. in medical biophysics from the University of Toronto .

Board of Directors:

Chair: Donovan Yeates, Ph.D. CEO, KAER Biotherapeutics

Ian Wisenberg, BC., CPA, CFO, Managing Partner, BioGlobalConsulting Group; Finance and Business Development

Stephen Chang, Ph.D. CEO, MultiCell Technologies, Inc; R&D and Business Development.

Anthony Hickey, Ph.D., CEO, Cirrus Pharmaceuticals; Pharmaceutics and Respiratory Drug Delivery